Literature DB >> 2564894

Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity.

H M Deutsch1, J A Glinski, M Hernandez, R D Haugwitz, V L Narayanan, M Suffness, L H Zalkow.   

Abstract

Taxol has shown good in vivo antitumor activity in a number of test systems. The formulation of taxol for antitumor testing has been difficult. Esterification at either C-2' or C-7 resulted in loss of in vitro tubulin assembly activity but not cytotoxicity. These observations suggested that esters at C-2' and/or C-7, which would tend to promote water solubility, might serve as useful prodrugs of taxol. The reaction of taxol with either succinic anhydride or glutaric anhydride in pyridine solution at room temperature gave the crystalline mono 2'-adducts 1b and 1f, respectively. Salts of these acids (1b, 1f, 1i) were formed by the addition of 1 equiv of the corresponding base, followed by evaporation and/or freeze-drying of the solvent(s). The salts had improved antitumor activity as compared to the free acids. The triethanolamine and N-methylglucamine salts showed greatly improved aqueous solubility and were more active than the sodium salts. The glutarate series was preferred because of the higher activity and the higher yields obtained. 2'-Glutaryltaxol (1f) was coupled with 3-(dimethylamino)-1-propylamine, using CDI, to form in excellent yield the amino amide 1o. The hydrochloride salt (1p) showed good solubility and was extremely potent and active. At 10 mg/kg, in the B16 screen, 1p gave a T/C of 352 with 5 out of 10 cures. In the MX-1 breast xenograft assay, this prodrug gave values of -100 at doses of 40 and 20 mg/kg, with all live animals being tumor free.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2564894     DOI: 10.1021/jm00124a011

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  33 in total

1.  Antitumor agents. 258. Syntheses and evaluation of dietary antioxidant--taxoid conjugates as novel cytotoxic agents.

Authors:  Kyoko Nakagawa-Goto; Koji Yamada; Seikou Nakamura; Tzu-Hsuan Chen; Po-Cheng Chiang; Kenneth F Bastow; Shao-Chun Wang; Bill Spohn; Mien-Chie Hung; Fang-Yu Lee; Fang-Chen Lee; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem Lett       Date:  2007-07-04       Impact factor: 2.823

2.  Strategy for increasing drug solubility and efficacy through covalent attachment to polyvalent DNA-nanoparticle conjugates.

Authors:  Xue-Qing Zhang; Xiaoyang Xu; Robert Lam; David Giljohann; Dean Ho; Chad A Mirkin
Journal:  ACS Nano       Date:  2011-08-12       Impact factor: 15.881

3.  A differential scanning calorimetry study of phosphocholines mixed with paclitaxel and its bromoacylated taxanes.

Authors:  S Ali; S Minchey; A Janoff; E Mayhew
Journal:  Biophys J       Date:  2000-01       Impact factor: 4.033

4.  Photoacoustic Imaging Quantifies Drug Release from Nanocarriers via Redox Chemistry of Dye-Labeled Cargo.

Authors:  Ananthakrishnan Soundaram Jeevarathinam; Jeanne E Lemaster; Fang Chen; Eric Zhao; Jesse V Jokerst
Journal:  Angew Chem Int Ed Engl       Date:  2020-01-24       Impact factor: 15.336

5.  Synthesis and Biological Evaluation of a Biotinylated Paclitaxel With an Extra-Long Chain Spacer Arm.

Authors:  Lev G Lis; Mary A Smart; Anna Luchniak; Mohan L Gupta; Vadim J Gurvich
Journal:  ACS Med Chem Lett       Date:  2012-07-30       Impact factor: 4.345

6.  Synthesis and preliminary biological evaluation of high-drug-load paclitaxel-antibody conjugates for tumor-targeted chemotherapy.

Authors:  Sherly Quiles; Kevin P Raisch; Leisa L Sanford; James A Bonner; Ahmad Safavy
Journal:  J Med Chem       Date:  2010-01-28       Impact factor: 7.446

7.  Kinetics of paclitaxel 2'-N-methylpyridinium mesylate decomposition.

Authors:  Jaber G Qasem; Paul M Bummer; George A Digenis
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

8.  Chemical conjugation of muramyl dipeptide and paclitaxel to explore the combination of immunotherapy and chemotherapy for cancer.

Authors:  Xuqin Li; Junli Yu; Song Xu; Nan Wang; Hongzhen Yang; Zheng Yan; Guifang Cheng; Gang Liu
Journal:  Glycoconj J       Date:  2007-12-27       Impact factor: 2.916

9.  Genome-free viral capsids as multivalent carriers for taxol delivery.

Authors:  Wesley Wu; Sonny C Hsiao; Zachary M Carrico; Matthew B Francis
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

10.  Drug delivery with carbon nanotubes for in vivo cancer treatment.

Authors:  Zhuang Liu; Kai Chen; Corrine Davis; Sarah Sherlock; Qizhen Cao; Xiaoyuan Chen; Hongjie Dai
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.